XML 51 R39.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Segment reporting (Tables)
 9 Months Ended
May 31, 2024
Segment Reporting [Abstract]  
Reconciliation of Operating Income (Loss) from Segments to Consolidated
The following table reflects results of operations of the Company’s reportable segments (in millions):

Three months ended May 31,Nine months ended May 31,
2024202320242023
Sales:
U.S. Retail Pharmacy$28,503 $27,866 $86,308 $82,648 
International5,727 5,573 17,581 16,414 
U.S. Healthcare2,125 1,975 6,232 4,597 
Corporate and Other 1
(3)— (9)— 
Walgreens Boots Alliance, Inc.$36,351 $35,415 $110,111 $103,659 
Adjusted operating income:
U.S. Retail Pharmacy$501 $962 $1,947 $3,134 
International175 208 562 676 
U.S. Healthcare(22)(172)(151)(483)
Corporate and Other 1
(42)(39)(158)(139)
Walgreens Boots Alliance, Inc.$613 $959 $2,200 $3,188 

1.Includes certain eliminations.

The following table reconciles adjusted operating income to operating income (loss) (in millions):

Three months ended May 31,Nine months ended May 31,
2024202320242023
Adjusted operating income (Non-GAAP measure)$613 $959 $2,200 $3,188 
Acquisition-related amortization(266)(274)(811)(851)
Transformational cost management(95)(414)(401)(697)
Acquisition-related costs(68)(70)(480)(257)
Adjustments to equity earnings in Cencora(57)(61)(129)(178)
Certain legal and regulatory accruals and settlements(52)(268)(376)(7,249)
LIFO provision36 (51)(11)(89)
Impairment of goodwill, intangibles and long-lived assets— (299)(13,091)(299)
Operating income (loss) (GAAP measure)$111 $(477)$(13,099)$(6,431)